Hormone Receptor Status and TN Stage Influence the Locoregional Benefit From Trastuzumab in Patients With HER 2–Positive Breast Cancer After Adjuvant Radiation Therapy
2014 ◽
Vol 90
(1)
◽
pp. S244-S245
2015 ◽
Vol 15
(5)
◽
pp. 381-389
◽
2020 ◽
Vol 108
(5)
◽
pp. 1150-1158
2010 ◽
Vol 3
(3)
◽
pp. 109-115
◽
2016 ◽
Vol 96
(2)
◽
pp. E9-E10
◽
2016 ◽
Vol 96
(2)
◽
pp. E52
2008 ◽
Vol 26
(15_suppl)
◽
pp. 545-545
◽